Lidds AB (LIDDS) - Total Liabilities

Latest as of September 2025: Skr491.00K SEK ≈ $52.84K USD

Based on the latest financial reports, Lidds AB (LIDDS) has total liabilities worth Skr491.00K SEK (≈ $52.84K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Lidds AB - Total Liabilities Trend (2010–2024)

This chart illustrates how Lidds AB's total liabilities have evolved over time, based on quarterly financial data. See Lidds AB working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Lidds AB Competitors by Total Liabilities

The table below lists competitors of Lidds AB ranked by their total liabilities.

Company	Country	Total Liabilities
MEDIMI AB AK F:79T	Germany	€1.37 Million
Kavango Resources PLC LSE:KAV	UK	GBX937.00K
Israel Opportunity - Energy Resources LP TA:ISOP-L	Israel	ILA259.00K
Wildpack Beverage Inc V:CANS	Canada	CA$141.24 Million
Alkemy Capital Investments Plc LSE:ALK	UK	GBX2.81 Million
Reco International Group Inc V:RGI	Canada	CA$3.57 Million
Vaxil Bio Ltd V:VXL	Canada	CA$8.00K
BLUERUSH Media Group Corp V:BTV	Canada	CA$7.19 Million

Liability Composition Analysis (2010–2024)

This chart breaks down Lidds AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LIDDS stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.04	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	3.53	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Lidds AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Lidds AB (2010–2024)

The table below shows the annual total liabilities of Lidds AB from 2010 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr1.98 Million ≈ $212.97K	-47.31%
2023-12-31	Skr3.76 Million ≈ $404.21K	-64.47%
2022-12-31	Skr10.57 Million ≈ $1.14 Million	+49.58%
2021-12-31	Skr7.07 Million ≈ $760.52K	-37.99%
2020-12-31	Skr11.40 Million ≈ $1.23 Million	+91.05%
2019-12-31	Skr5.96 Million ≈ $641.91K	+22.76%
2018-12-31	Skr4.86 Million ≈ $522.91K	+36.48%
2017-12-31	Skr3.56 Million ≈ $383.16K	-58.06%
2016-12-31	Skr8.49 Million ≈ $913.69K	+229.98%
2015-12-31	Skr2.57 Million ≈ $276.89K	+10.96%
2014-12-31	Skr2.32 Million ≈ $249.55K	+47.07%
2013-12-31	Skr1.58 Million ≈ $169.68K	-55.24%
2012-12-31	Skr3.52 Million ≈ $379.11K	+107.08%
2011-12-31	Skr1.70 Million ≈ $183.08K	+42.38%
2010-12-31	Skr1.19 Million ≈ $128.59K	--

About Lidds AB

ST:LIDDS Sweden Biotechnology

Market Cap

$361.27K

Skr3.36 Million SEK

Market Cap Rank

#30942 Global

#733 in Sweden

Share Price

Skr0.02

Change (1 day)

+0.00%

52-Week Range

Skr0.01 - Skr0.10

All Time High

Skr19.64